Abstract
Background: Osteosarcoma (OS) is a common disease in the world, and its pathogenesis is still unclear. This study aims to identify the key genes that promote the proliferation, invasion, and metastasis of osteosarcoma cells.Method: GSE124768 and GSE126209 were downloaded from the Gene Expression Omnibus (GEO) database. The gene ontology and enrichment pathway were analyzed by FunRich software. qPCR and Western blot were used to detect the gene expression. After gene knockdown, Transwell and wound healing assays were conducted on osteosarcoma cells to detect whether the genes were defined before enhancing the invasion of osteosarcoma.Results: Totally, 341 mRNAs were found to be regulated differentially in osteosarcoma cells compared to osteoblasts. In addition, the expression level of Serglycin (SRGN) in osteosarcoma cells was higher than that in human osteoblasts. The invasion and proliferation ability of osteosarcoma cells with upregulated Serglycin was significantly increased, and on the contrary, decreased after Serglycin knockdown. Moreover, we preliminarily found that Serglycin may associate with the JAK/STAT signaling pathway.Conclusions: By using microarray and bioinformatics analyses, differently expressed mRNAs were identified and a complete gene network was constructed. To our knowledge, we describe for the first time Serglycin as a potential biomarker.
Highlights
Osteosarcoma (OS) represents the most common malignant bone tumors with high metastatic potential and poor prognosis in adolescents under the age of 20 [1]
KEGG pathway analysis showed that these potential target genes were mainly enriched in 6 pathways including the PPAR signaling pathway, Peroxisome, Hippo signaling pathway, Tight junction, HIF-1 signaling pathway, and Pathogenic Escherichia coli infection (Figure 2B)
We identified 352 gene expression patterns related to cancer, indicating that these 352 genes play an important role in promoting the development of osteosarcoma
Summary
Osteosarcoma (OS) represents the most common malignant bone tumors with high metastatic potential and poor prognosis in adolescents under the age of 20 [1]. It usually occurs in rapidly developing bones, such as the humerus, distal femur, or proximal tibia. It is a highly aggressive malignant tumor, often www.aging-us.com metastasizing to the lungs and other organs [2]. The invasion and proliferation ability of osteosarcoma cells with upregulated Serglycin was significantly increased, and on the contrary, decreased after Serglycin knockdown. We describe for the first time Serglycin as a potential biomarker
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
